RAYMOND JAMES & ASSOCIATES, INC. | 705 | P2 Capital Fund, Ltd. | 1409505 | 12/14/2018 | D/A | Indefinite | $109,648,000 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | EAGLE GROWTH PARTNERS II, LP | 1415629 | 01/22/2018 | D/A | Indefinite | $108,724,664 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | EAGLE GROWTH PARTNERS II, LP | 1415629 | 02/12/2019 | D/A | Indefinite | $108,724,664 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | EAGLE GROWTH PARTNERS II, LP | 1415629 | 02/11/2020 | D/A | Indefinite | $108,724,664 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | EAGLE GROWTH PARTNERS II, LP | 1415629 | 02/02/2021 | D/A | Indefinite | $108,724,664 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | EAGLE GROWTH PARTNERS II, LP | 1415629 | 01/26/2022 | D/A | Indefinite | $108,724,664 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | EAGLE GROWTH PARTNERS II, LP | 1415629 | 01/30/2023 | D/A | Indefinite | $108,724,664 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | EAGLE GROWTH PARTNERS II, LP | 1415629 | 02/01/2017 | D/A | Indefinite | $107,575,764 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | Carlyle Private Equity Access Fund 2014, L.P. | 1624393 | 06/17/2015 | D/A | Indefinite | $107,479,000 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | ZIOPHARM ONCOLOGY INC | 1107421 | 08/09/2019 | D | $105,106,064 | $105,106,064 |